SATB2 and neoplasm: Yu et al. [5] found that miR-31-5p contributed to tumor progression both in vitro and in vivo by directly targeting Special AT-Rich Sequence-Binding Protein 2 (SATB2)—it reversed the epithelial–mesenchymal transition and significantly increased activation of MEK/ERK signaling.